Novocure Ltd Ord Sh (NVCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 155,095 | 150,356 | 138,503 | 133,784 | 127,321 |
| Cost of Goods | 35,372 | 34,654 | 33,689 | 32,556 | 32,092 |
| Gross Profit | 119,723 | 115,702 | 104,814 | 101,228 | 95,229 |
| Operating Expenses | 152,187 | 149,936 | 147,023 | 153,500 | 153,566 |
| Operating Income | -32,092 | -33,580 | -41,520 | -51,716 | -58,245 |
| Interest Expense | -10,507 | -10,851 | -9,878 | -13,182 | -10,023 |
| Pre-tax Income | -21,585 | -22,729 | -31,642 | -38,534 | -48,222 |
| Income Tax | 8,985 | 10,646 | 7,118 | 8,545 | 1,263 |
| Net Income Continuous | -30,570 | -33,375 | -38,760 | -47,079 | -49,485 |
| Net Income | $-30,570 | $-33,375 | $-38,760 | $-47,079 | $-49,485 |
| EPS Basic Total Ops | -0.28 | -0.31 | -0.36 | -0.45 | -0.46 |
| EPS Basic Continuous Ops | -0.28 | -0.31 | -0.36 | -0.44 | -0.46 |
| EPS Diluted Total Ops | -0.28 | -0.31 | -0.36 | -0.45 | -0.46 |
| EPS Diluted Continuous Ops | -0.28 | -0.31 | -0.36 | -0.44 | -0.46 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.31 | -0.36 | N/A | N/A |
| EBITDA(a) | $-36,371 | $-37,576 | $-44,086 | $-56,255 | $-62,133 |